載入...
NSCLC molecular testing in Central and Eastern European countries
BACKGROUND: The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC) has highlighted the importance of accurate molecular diagnosis to determine if an actionable genetic alteration is present. Few data are available for Central and Eastern Europe (CEE) on mutation ra...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5845184/ https://ncbi.nlm.nih.gov/pubmed/29523116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4023-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|